AIHealthcare

AI-in-Healthcare Intelligence Platform

OM1

Healthcare AI Real-world evidence, clinical data analytics, predictive medicine, clinical registries, and personal Series D (latest publicly reported financing: $85M

OM1, Inc. is a Boston-based healthcare technology and data company focused on real-world evidence, personalized medicine, clinical registries, and predictive healthcare AI. Its platform combines deep longitudinal clinical data with artificial intelligence to identify patient phenotypes, accelerate diagnosis and research, estimate treatment effects, predict medical events and outcomes, support regulatory-grade evidence generation, and inform clinical and commercial decision-making. OM1 reports that its PhenOM® healthcare foundation model is trained on more than 1 billion patient-years and that its Real-World Data Cloud covers more than 350 million individuals, using linked electronic medical record, claims, laboratory, specialty-network, social-determinants, and mortality data. Its offerings include PhenOM®, OM1 Aspen for automated study and evidence generation, and products such as Orion, Lyra, and Polaris. The company serves life-sciences, healthcare, research, and government organizations and positions itself as an AI-enabled real-world data and outcomes platform for chronic and specialty conditions.

Company Details

Website
om1.com
Headquarters
Boston, Massachusetts, United States
Founded
2015
Funding
$171M-$176.25M reported across four rounds; the difference reflects varying database methodologies

Subscriber Intelligence

  • • Deal signal alerts for this company
  • • Sentiment & risk scoring
  • • Competitive framework analysis
  • • Regulatory event monitoring
← Back to Company Directory